The use of electronic cigarettes is being encouraged as a way of escaping from the harm resulting from conventional tobacco smoking, while scant attention is being paid to the long-term risks of inhaling electronic cigarette vapour. More information is needed for an acceptable risk assessment, from integrated non-animal testing and sound clinical investigations
Get full access to this article
View all access options for this article.
References
1.
KnightF.H. (1921). Risk, Uncertainty and Profit, 381 pp. Boston, MA, USA: Hart, Schaffner & Marx; Houghton Mifflin Company.
2.
BallsM. (2006). On facing up to risk and uncertainty in relation to animal and non-animal safety testing. ATLA34, 547–549.
3.
CombesR.D., & BallsM. (2015). A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products. ATLA43, 251–290.
CombesR.D., & BallsM. (2015). On the safety of E-cigarettes: “I can resist anything except temptation”. ATLA43, 417–425.
6.
Anon. (2018). E-cigarettes, Seventh Report of Session 2017–2019, HC 505, 66 pp. London, UK: House of Commons Science and Technology Committee.
7.
Ungoed-ThomasJ., & NealW. (2018). Kiddie vapes are trick, not treat. The Sunday Times, 14 October 2018, p. 4.
8.
MeddingsS. (2018). Imps claims vaping wins over smokers. The Sunday Times, 4 November 2018, Business section, p. 2.
9.
CombesR.D., & BallsM. (2018). A replacement perspective on inhalation toxicology. In The History of Alternative Test Methods in Toxicology (ed. BallsM., CombesR.D., & WorthA.), pp. 197–208. New York, NY, USA: Elsevier/Academic Press.
